Drug Target: Identification and Mechanism of Action
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 4196
Special Issue Editor
Special Issue Information
Dear Colleagues,
Drug target identification and mechanism of action (MoA) studies are essential for the development of novel drugs. The target is the molecule or cellular process that the drug will interact with to produce its desired effect. The MoA is the biochemical or cellular pathway via which the drug exerts its effect. The aims of this Special Issue are as follows:
- Provide a forum for the latest advances in drug target identification and MoA studies.
- Promote interdisciplinary collaboration between chemists, biologists, and medicinal chemists.
- Highlight the importance of drug target identification and MoA studies in the development of new drugs to treat diseases.
Topics of interest for this Special Issue include, but are not limited to, the following:
- The mechanism of action of new and existing drugs;
- The discovery and development of new drug targets;
- The design and optimization of new drug molecules;
- The use of biochemical, genetic, and cellular approaches to identify drug targets;
- The use of computational methods to predict drug targets;
- The study of the MoA of known drug targets;
- The development of new methods for drug target identification and MoA studies.
Dr. Srijan Acharya
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacology
- drug discovery
- drug targets
- receptors function
- target validation
- chemical biology
- lead optimization
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
